Chemotherapy-Induced Neuropathy: What It Is and How to Manage It
Peripheral neuropathy from chemotherapy causes numbness, tingling, and pain in hands and feet. Here's why it happens, which drugs cause it, and what helps.
OncoNav Medical Team·June 5, 2025·7 min read
## What Is Chemotherapy-Induced Peripheral Neuropathy?
**CIPN (Chemotherapy-Induced Peripheral Neuropathy)** is damage to the peripheral nerves — the nerves outside the brain and spinal cord — caused by certain chemotherapy drugs.
It typically affects the hands and feet first (a "stocking-glove" distribution) and can cause:
- Numbness
- Tingling (pins and needles)
- Burning pain
- Electric shock-like sensations
- Sensitivity to cold (particularly with oxaliplatin)
- Loss of fine motor skills (difficulty with buttons, writing)
- Balance problems and increased fall risk
## Which Drugs Cause CIPN?
| Drug Class | Examples | Neuropathy Profile |
|---|---|---|
| Platinums | Oxaliplatin, cisplatin, carboplatin | Numbness, tingling, acute cold sensitivity (oxaliplatin) |
| Taxanes | Paclitaxel, docetaxel | Numbness, tingling, pain; paclitaxel particularly culpable |
| Vinca alkaloids | Vincristine, vinorelbine | Significant neuropathy risk |
| Proteasome inhibitors | Bortezomib (Velcade) | Common in multiple myeloma treatment |
| Thalidomide/lenalidomide | — | Multiple myeloma; thalidomide has high neuropathy rate |
## How Common Is It?
CIPN affects approximately **30–40% of patients** on neurotoxic regimens. Severity ranges from mild and temporary to severe and permanent.
Risk factors for worse CIPN:
- Higher cumulative drug doses
- Pre-existing diabetes or neuropathy
- Older age
- Alcohol use
- Genetic factors
## Can CIPN Be Prevented?
Unfortunately, no proven prevention strategy exists. Some things that do NOT help (despite being studied):
- Calcium/magnesium infusions with oxaliplatin (once thought helpful, not proven)
- Vitamin B6 supplements — can actually worsen neuropathy in high doses
**Dose modification** — reducing or pausing the neurotoxic drug — is the most effective way to prevent CIPN from worsening. Tell your oncologist immediately when symptoms start.
## Treatment for CIPN
**First-line:**
- **Duloxetine (Cymbalta)** — the only medication with strong evidence for painful CIPN; shown to reduce pain in randomized trials
- Modest but real benefit; works for pain more than numbness
**Other medications used:**
- Gabapentin or pregabalin — modest evidence, widely used
- Tricyclic antidepressants (amitriptyline) — some evidence for neuropathic pain
- Topical agents (menthol, lidocaine, ketamine creams) — local relief
**Non-pharmacologic:**
- **Physical therapy** — important for balance problems and fall prevention
- Acupuncture — some evidence for pain relief
- Exercise — may help nerve recovery
- Occupational therapy for fine motor difficulties
## Will It Go Away?
- For many patients, CIPN improves or resolves within 6–18 months after stopping the causative drug
- For some, particularly with high cumulative cisplatin or oxaliplatin doses, some degree of neuropathy may be permanent
- Early reporting to your oncologist (before symptoms become severe) gives the best chance of recovery
⚠️ Medical Disclaimer:This article is for informational and educational purposes only. It is not medical advice and does not replace the guidance of your oncologist, physician, or qualified healthcare provider. Every patient's situation is unique — symptoms, treatment decisions, and urgent care needs vary based on your individual diagnosis, treatment plan, and medical history. Always consult your oncologist or care team regarding any symptoms, concerns, or questions about your care — including decisions about whether to seek emergency care or stay home. Do not delay seeking professional medical attention based on information in this article. If you are experiencing a medical emergency, call 911 immediately.
Take Control of Your Cancer Journey
OncoNav helps patients understand their diagnosis, prepare for appointments, organize medical information, and track their treatment journey.